【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Leukemia Overview 8
3 Products under Development 9
3.1 Leukemia – Pipeline Products by Stage of Development 9
3.2 Leukemia – Pipeline Products by Territory 10
3.3 Leukemia – Pipeline Products by Regulatory Path 11
3.4 Leukemia – Pipeline Products by Estimated Approval Date 12
4 Leukemia – Pipeline Products under Development by Companies 13
4.1 Leukemia Companies – Pipeline Products by Stage of Development 13
4.2 Leukemia – Pipeline Products by Stage of Development 15
5 Leukemia Companies and Product Overview 18
5.1 Abbott Diagnostics Company Overview 18
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Acobiom Company Overview 22
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Adaptive Biotechnologies Corporation Company Overview 23
5.3.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 BioSense Technologies, Inc. Company Overview 24
5.4.1 BioSense Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Cancer Genetics, Inc. Company Overview 25
5.5.1 Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Cepheid Company Overview 27
5.6.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Di.V.A.L Toscana srl Company Overview 29
5.7.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Diagnovus, LLC Company Overview 30
5.8.1 Diagnovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 DiaSorin S.p.A Company Overview 31
5.9.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Eutropics Pharmaceuticals, Inc. Company Overview 37
5.10.1 Eutropics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 Gendiag Company Overview 41
5.11.1 Gendiag Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Health Discovery Corporation Company Overview 42
5.12.1 Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 InVivoScribe Technologies, Inc. Company Overview 44
5.13.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 IV Diagnostics, Inc. Company Overview 46
5.14.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Jaden BioScience Inc. Company Overview 47
5.15.1 Jaden BioScience Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 MolecularMD, Corp. Company Overview 48
5.16.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Monoquant Pty. Ltd. Company Overview 49
5.17.1 Monoquant Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Nodality, Inc. Company Overview 50
5.18.1 Nodality, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 NuCana BioMed Limited Company Overview 51
5.19.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Nuclea Biotechnologies Inc. Company Overview 59
5.20.1 Nuclea Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.21 OncoVista Innovative Therapies, Inc. Company Overview 62
5.21.1 OncoVista Innovative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Qiagen N.V. Company Overview 64
5.22.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 64
5.23 Siemens Healthcare Diagnostics Inc. Company Overview 66
5.23.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Skyline Diagnostics BV Company Overview 68
5.24.1 Skyline Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 68
5.25 St. Jude Children’s Research Hospital, Inc. Company Overview 70
5.25.1 St. Jude Children’s Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.26 The Feinstein Institute for Medical Research Company Overview 73
5.26.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 University of Barcelona Company Overview 75
5.27.1 University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview 75
5.28 University of California, San Diego Company Overview 76
5.28.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 University of Missouri Company Overview 78
5.29.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 Vela Diagnostics Company Overview 79
5.30.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Vivia Biotech, S.L. Company Overview 80
5.31.1 Vivia Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Wake Forest Baptist Medical Center Company Overview 83
5.32.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Xiamen Zeesan Biotech Co.,Ltd Company Overview 85
5.33.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
6 Leukemia- Recent Developments 87
7 Appendix 90
7.1 Methodology 90
7.2 About GlobalData 92
7.3 Contact Us 93
7.4 Disclaimer 93
【レポート販売概要】
■ タイトル：世界における白血病検査製品のパイプライン動向2015■ 英文：Leukemia - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0073EPD
■ 調査対象地域：グローバル
- 塩素酸ナトリウムの世界市場予測Sodium chlorate 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about sodium chlorate market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytica …
- ユニファイドコミュニケーションの世界市場分析：製品別（オンプレミス、、クラウドベース/ホスト）、用途別（企業、教育、行政、ヘルスケア）、セグメント予測The global unified communications market size is expected to reach USD 143.49 billion by 2024, according to a new report by Grand View Research, Inc. The substantial growth prospects of the unified communications market can be attributed to the rapid international expansion of organizations and an increasing need for real-time and efficient communication systems that enhance the inter-organization …
- スマート抗菌性コーティング及び表面の世界市場Smart antimicrobial coatings and surfaces represent an important element of the smart materials space. The market for smart antimicrobial coatings and surfaces is driven by the need to selectively combat new threats from bacteria, viruses and fungi. Also important to the future of smart antimicrobial coatings is the mandate to reduce hospital-acquired infections. But, the opportunity for antimicro …
- Lynden Energy Corp.：石油・ガスの開発・生産動向及びコスト分析– 2012Lynden Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Lynden Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- Diabetic Neuropathy：グローバル臨床試験レビューH2, 2013Diabetic Neuropathy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H2, 2013" provides data on the Diabetic Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Neuropathy. It includes an overview of the trial numbers and their recru …
- エンジニアードフォームの世界市場予測（～2026）：ポリウレタン、ポリスチレン、ポリオレフィンThe global engineered foam market is projected to reach USD 122.30 Billion by 2026, at a CAGR of 7.9% from 2016 to 2026. High transition along with shorter product life cycles in end-use industries is another factor expected to drive the engineered foam market. Increase in the number of developments in the construction, sports & leisure, and automotive industries is also expected to further boost …
- 航空貨物フォワーディングの世界市場2017-2021About Airfreight ForwardingAirfreight forwarding represents 1% of global trade by volume and 35% by value of global goods distribution network. The airfreight forwarding industry has major customers distributed across many verticals. Major customers include the manufacturing industries such as industrial and automation components, fast moving consumer goods (FMCG) and retail, and healthcare, pharm …
- CMS Energy Corporation：発電所及び企業SWTO分析2015CMS Energy Corporation - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized …
- パラキシレンの世界市場：用途及び地域別分析The global paraxylene market, in terms of value, is estimated to grow at a CAGR of 11.3% from 2014 to 2019. Asia-Pacific held the largest share 83.0% of the global paraxylene market in 2014, followed by the North American segment, which is expected to grow at a CAGR of 9.3% during the forecast period of 2014 to 2019. In this report, the global paraxylene market has been broadly classified on the b …
- 自動車用アクティブシートベルト装置の世界市場2017-2021About Automotive Active Seat Belt System Automotive active seat belt systems consist of electrically driven active retractors, pretensioners, and buckle lifters. The pretensioner tightens or loosens the belt slack as per the road situation. During a hazardous road traffic situation, such as a sudden application of the brakes or the vehicle skidding, the pretensioner in the active seat belt system …
- n‐ブタノールの世界市場N-Butanol (CAS 71-36-3) Market Research Report 2013 presents comprehensive data on N-butanol markets globally and regionally (Europe, Asia, North America etc.) The N-Butanol (CAS 71-36-3) Market Research Report 2013 includes N-butanol description, covers its application areas and related patterns. It overviews N-butanol market, names N-butanol producers and indicates its suppliers. Besides, the N- …
- 中国の再生可能エネルギー市場分析：Analyzing Renewable Energy in ChinaChina’s rapid economic growth and heavy reliance on increasingly expensive foreign oil, the vast environmental toll that is one of the most apparent costs of China's economic success, persistent rural poverty in China and periodic power shortages all have impressed upon the Chinese government that renewable energy must be a large part of China's economy if China is to both complete its economic tr …
- Cholestasis：グローバル臨床試験レビューH1, 2013Cholestasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cholestasis Global Clinical Trials Review, H1, 2013" provides data on the Cholestasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholestasis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- モバイル仮想ネットワークオペレータ（MVNO）の世界市場分析、セグメント予測、-2010The global MVNO market is expected to reach USD 73.20 billion by 2020. Increasing global mobile subscribers and demand for data services is expected to favor market growth over the next six years. MVNOs provide differentiated services to customers by targeting niche market segments such as retail, business, roaming, etc. This helps to avoid direct competition with MNOs and also generates additiona …
- 行動リハビリの世界市場の規模および予測：用途別（不安、気分障害、物質乱用、人格、注意欠陥障害）、医療現場別（入院患者、家庭内、外来患者）、動向の分析 2014-2025The global behavioral rehabilitation market is expected to reach USD 313.9 billion by 2025, according to a new report by Grand View Research, Inc. Behavioral rehabilitation market is anticipated to experience growth during the forecast period due to presence of favorable government initiatives, rising number of service providers, and growing awareness among patients. Furthermore, increasing incide …
